Michigan bluegrass phenom Billy Strings and his band stopped by NPR’s Tiny Desk for a performance more than a decade in the making. Backed by his band — Alex Hargreaves on fiddle, backing vocalist ...

Strings will be performing at the Fishers Event Center on Friday, April 24 and Saturday, April 25, 2026. The tour extension is in support of his latest full-length album, "Highway Prayers, which was ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Billy Strings is opening up about the unexpected death of his mother, Debra Apostal, which happened in June. Strings — whose legal name is William Lee Apostal — says his mom wasn't sick leading up to ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

In what has become a lauded Halloween tradition, Billy Strings staged a spectacle at the CFG Bank Arena in Baltimore on October 31. Before the band made their grand entrance, the stage screen mimicked ...

Q. I have used the Excel functions LEFT, MID, and RIGHT to dissect cells. However, I have some spreadsheets where each piece of information is a different length and uses different delimiters. Is ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...